Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vahid Asnafi

Showing results (1-10 of 180) with videos related to

Pageof 18
Sort By:
Blood|November 15, 2014
HiJAKing T-ALLVahid Asnafi
Medecine Sciences : M/S|August 28, 2012
[Deciphering functional activity of TLX homeodomain oncogenes in T-ALL: a clue for a differentiating therapy?]Vahid Asnafi, Pierre Ferrier
Blood|April 25, 2012
Erythroid leukemia evolving from multiple myelomaChantal Brouzes, Vahid Asnafi
Haematologica|July 25, 2024
Drive to survive: gene dependency in T-cell acute lymphoblastic leukemiaGuillaume P Andrieu, Vahid Asnafi
Blood|April 29, 2021
Integrated omics approaches to predict T-LBL relapse riskGuillaume P Andrieu, Vahid Asnafi
Best Practice & Research. Clinical Haematology|February 8, 2005
Clinical impact of molecular diagnostics in low-grade lymphomaMariem Bahloul, Vahid Asnafi, Elizabeth Macintyre
International Journal of Cancer|January 3, 2025
Neo-enhancers in T-cell acute lymphoblastic Leukaemia (T-ALL) and beyondCharlotte Smith, Vahid Asnafi, Aurore Touzart
Blood Advances|June 18, 2026
Caution in Interpreting Prognostic Genomic Factors in Underpowered Subgroups of Children with T-ALLMathieu Simonin, André Baruchel, Vahid Asnafi
Oncotarget|September 23, 2015
RUNX1 as a recombinase cofactorAgata Cieslak, Dominique Payet-Bornet, Vahid Asnafi
Blood|May 2, 2009
TGF-beta induces degradation of TAL1/SCL by the ubiquitin-proteasome pathway through AKT-mediated phosphorylationJean-Michel Terme, Ludovic Lhermitte, Vahid Asnafi, et al.
Pageof 18

Showing results (1-10 of 180) with videos related to

Sort By:
Pageof 18
Blood|November 15, 2014
HiJAKing T-ALLVahid Asnafi
Medecine Sciences : M/S|August 28, 2012
[Deciphering functional activity of TLX homeodomain oncogenes in T-ALL: a clue for a differentiating therapy?]Vahid Asnafi, Pierre Ferrier
Blood|April 25, 2012
Erythroid leukemia evolving from multiple myelomaChantal Brouzes, Vahid Asnafi
Haematologica|July 25, 2024
Drive to survive: gene dependency in T-cell acute lymphoblastic leukemiaGuillaume P Andrieu, Vahid Asnafi
Blood|April 29, 2021
Integrated omics approaches to predict T-LBL relapse riskGuillaume P Andrieu, Vahid Asnafi
Best Practice & Research. Clinical Haematology|February 8, 2005
Clinical impact of molecular diagnostics in low-grade lymphomaMariem Bahloul, Vahid Asnafi, Elizabeth Macintyre
International Journal of Cancer|January 3, 2025
Neo-enhancers in T-cell acute lymphoblastic Leukaemia (T-ALL) and beyondCharlotte Smith, Vahid Asnafi, Aurore Touzart
Blood Advances|June 18, 2026
Caution in Interpreting Prognostic Genomic Factors in Underpowered Subgroups of Children with T-ALLMathieu Simonin, André Baruchel, Vahid Asnafi
Oncotarget|September 23, 2015
RUNX1 as a recombinase cofactorAgata Cieslak, Dominique Payet-Bornet, Vahid Asnafi
Blood|May 2, 2009
TGF-beta induces degradation of TAL1/SCL by the ubiquitin-proteasome pathway through AKT-mediated phosphorylationJean-Michel Terme, Ludovic Lhermitte, Vahid Asnafi, et al.
Pageof 18